Evidence map›Paper›PMID 32854531›Full record

ArticleThe American journal of psychiatry2020

Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI.

Clifford M Cassidy, Kenneth M Carpenter, Anna B Konova, Victoria Cheung, Alexander Grassetti, Luigi Zecca, Anissa Abi-Dargham, Diana Martinez, Guillermo Horga

Open access · greenAbstract read
In one paragraph

Article in The American journal of psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Clifford M CassidyUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Kenneth M CarpenterUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Anna B KonovaUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Victoria CheungUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Alexander GrassettiUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Luigi ZeccaUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Anissa Abi-DarghamUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Diana MartinezUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
Guillermo HorgaUniversity of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa (Cassidy, Cheung); Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York (Cassidy, Carpenter, Grassetti, Abi-Dargham, Martinez, Horga); Department of Psychiatry, Rutgers University, Piscataway, N.J. (Konova); Institute of Biomedical Technologies, National Research Council of Italy, Milan (Zecca); Department of Psychiatry, Stony Brook University, Stony Brook, N.Y. (Abi-Dargham).
National Academies of Sciences, Engineering, and Medicine · US

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Deficient Belief Updating as a Convergent Computational Mechanism of PsychosisR01MH114965 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HORGA, GUILLERMO · 2018 to 2022
$3.6M
Individualized risk prediction in persons at clinical high-risk for psychosis using neuromelanin-sensitive MRI.R01MH117323 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HORGA, GUILLERMO · 2018 to 2022
$3.3M
Imaging the Neurobiology of a Behavioral Treatment for Cocaine DependenceR01DA020855 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI CARPENTER, KENNETH MICHAEL, MARTINEZ, DIANA M · 2005 to 2014
$2.6M
Using PET to Image the Neurochemistry of AddictionK02DA026525 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARTINEZ, DIANA M · 2009 to 2018
$1.3M
NCATS NIH HHS UL1 TR001873NIDA NIH HHS K02 DA026525NIDA NIH HHS R01 DA020855NIMH NIH HHS R01 MH114965NIMH NIH HHS R01 MH117323
6 · The paper itself

Abstract

objectiveRecent evidence supports the use of neuromelanin-sensitive MRI (NM-MRI) as a novel tool to investigate dopamine function in the human brain. The authors investigated the NM-MRI signal in individuals with cocaine use disorder, compared with age- and sex-matched control subjects, based on previous imaging studies showing that this disorder is associated with blunted presynaptic striatal dopamine.

methodsNM-MRI and T

resultsCompared with control subjects, cocaine users showed significantly increased NM-MRI signal in ventrolateral regions of the substantia nigra (area under the receiver operating characteristic curve=0.83). Exploratory analyses did not find a significant correlation of NM-MRI signal to activation of the ventral striatum during anticipation of monetary reward.

conclusionsGiven that previous imaging studies show decreased dopamine signaling in the striatum, the finding of increased NM-MRI signal in the substantia nigra provides additional insight into the pathophysiology of cocaine use disorder. One interpretation is that cocaine use disorder is associated with a redistribution of dopamine between cytosolic and vesicular pools, leading to increased accumulation of neuromelanin. The study findings thus suggest that NM-MRI can serve as a practical imaging tool for interrogating the dopamine system in addiction.

Indexed as

Anticipation, PsychologicalCase-Control StudiesCocaine-Related DisordersDopamineDopaminergic NeuronsFemaleHumansMaleMelaninsMiddle AgedNeuroimagingRewardSubstantia NigraVentral StriatumDopamineMelaninsneuromelaninCocaine Use DisorderDopamineNeuromelanin-Sensitive MRISubstantia Nigra

Identifiers

PMID32854531
PMCPMC9108998
OpenAlexW3081972371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.